Glaukos (STU:6GJ) Long-Term Debt : €260.5 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Glaukos Long-Term Debt?

Glaukos's Long-Term Debt for the quarter that ended in Mar. 2024 was €260.5 Mil.

Glaukos's quarterly Long-Term Debt declined from Sep. 2023 (€264.6 Mil) to Dec. 2023 (€259.3 Mil) but then increased from Dec. 2023 (€259.3 Mil) to Mar. 2024 (€260.5 Mil).

Glaukos's annual Long-Term Debt increased from Dec. 2021 (€247.8 Mil) to Dec. 2022 (€265.6 Mil) but then declined from Dec. 2022 (€265.6 Mil) to Dec. 2023 (€259.3 Mil).

Glaukos Long-Term Debt Historical Data

The historical data trend for Glaukos's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glaukos Long-Term Debt Chart

Glaukos Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

155.70

247.82

265.64

259.30

Glaukos Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															263.15	260.37	264.64	259.30	260.47

Glaukos (STU:6GJ) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Glaukos Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Glaukos's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Glaukos (STU:6GJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Glaukos Corp (STU:6GJ) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

GKOS:USA 6GJ:Germany

Address

One Glaukos Way, Aliso Viejo, CA, USA, 92656

Website

https://www.glaukos.com

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Glaukos (STU:6GJ) Headlines

No Headlines